# Rani Therapeutics (stock symbol: RANI) Logo in transparent PNG and SVG formats

## Rani Therapeutics Logo large

### Rani Therapeutics Logo large Download PNG (49.38 KB)

![Rani Therapeutics Logo large Download PNG (49.38 KB)](/img/orig/RANI_BIG-201d54d9.png)

### Rani Therapeutics Logo large Download SVG (4.83 KB)

![Rani Therapeutics Logo large Download SVG (4.83 KB)](/img/orig/RANI_BIG-682d5908.svg)

## Rani Therapeutics Logo icon format

### Rani Therapeutics Logo icon format Download PNG (18.2 KB)

![Rani Therapeutics Logo icon format Download PNG (18.2 KB)](/img/orig/RANI-934c749a.png)

### Rani Therapeutics Logo icon format Download SVG (898 Bytes)

![Rani Therapeutics Logo icon format Download SVG (898 Bytes)](/img/orig/RANI-959076f1.svg)

## Rani Therapeutics Logo large for dark backgrounds

### Rani Therapeutics Logo large for dark backgrounds Download PNG (26.51 KB)

![Rani Therapeutics Logo large for dark backgrounds Download PNG (26.51 KB)](/img/orig/RANI_BIG.D-76c5c71f.png)

### Rani Therapeutics Logo large for dark backgrounds Download SVG (4.8 KB)

![Rani Therapeutics Logo large for dark backgrounds Download SVG (4.8 KB)](/img/orig/RANI_BIG.D-f6fea0a7.svg)

## Rani Therapeutics Logo icon format for dark backgrounds

### Rani Therapeutics Logo icon format for dark backgrounds Download PNG (18.2 KB)

![Rani Therapeutics Logo icon format for dark backgrounds Download PNG (18.2 KB)](/img/orig/RANI.D-f7beaf2e.png)

### Rani Therapeutics Logo icon format for dark backgrounds Download SVG (898 Bytes)

![Rani Therapeutics Logo icon format for dark backgrounds Download SVG (898 Bytes)](/img/orig/RANI.D-92f15cfb.svg)

## About Rani Therapeutics

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

1. Website domain: ranitherapeutics.com
2. Employees: 114
3. Marketcap: $0.23 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
